Unbalanced Expression of the Different Subunits of Elongation Factor 1 in Diabetic Skeletal Muscle
In studies using subtraction cloning to screen for alterations in mRNA expression in skeletal muscle from humans with Type 2 diabetes mellitus and control subjects, one of the most prominent differences was in the mRNA for elongation factor (EF)-1α. With Northern blot analysis, EF-1α expression was...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 98; no. 6; pp. 3422 - 3427 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
13.03.2001
National Acad Sciences The National Academy of Sciences |
Subjects | |
Online Access | Get full text |
ISSN | 0027-8424 1091-6490 |
DOI | 10.1073/pnas.051630398 |
Cover
Summary: | In studies using subtraction cloning to screen for alterations in mRNA expression in skeletal muscle from humans with Type 2 diabetes mellitus and control subjects, one of the most prominent differences was in the mRNA for elongation factor (EF)-1α. With Northern blot analysis, EF-1α expression was enhanced by 2- to 6-fold in both Types 1 and 2 human diabetics. In contrast, no changes in expression of EF-1β or -γ were noted. We observed similar results in animal models of Type 1 diabetes. EF-1α expression, but not EF-1β or -γ expression, was also enhanced in streptozotocin-induced diabetic rats, and this effect was reversed by insulin treatment. An increased level of EF-1α mRNA was also observed in nonobese diabetic mice. This unbalanced regulation of the expression of the different subunits of EF-1 may contribute to alterations not only in protein synthesis but also in other cellular events observed in the diabetic state. |
---|---|
Bibliography: | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-2 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Contributed by C. Ronald Kahn To whom reprint requests should be addressed at: Research Division, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215. E-mail: c.ronald.kahn@joslin.harvard.edu. Present address: Diabetes Biology Department, Target Cell Biology Health Care Discovery Novo Nordisk Novo Alle 6A1.069, 2880 Bagsværd, Denmark. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.051630398 |